QUAKER CHEMICAL--FORM 10-Q
Table of Contents

SECURITIES AND EXCHANGE COMMISSION

Washington, D. C. 20549

 


 

FORM 10-Q

 


 

x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the quarterly period ended September 30, 2003

 

OR

 

¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the transition period from              to             

 

Commission file number 0-7154

 


 

QUAKER CHEMICAL CORPORATION

(Exact name of Registrant as specified in its charter)

 


 

Pennsylvania   23-0993790

(State or other jurisdiction of

incorporation or organization)

 

(I.R.S. Employer

Identification No.)

One Quaker Park, 901 Hector Street,

Conshohocken, Pennsylvania

  19428 – 0809
(Address of principal executive offices)   (Zip Code)

 

Registrant’s telephone number, including area code 610-832-4000

 


 

Not Applicable

Former name, former address and former fiscal year, if changed since last report.

 


 

Indicate by check mark whether the Registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    Yes  x    No  ¨

 

Indicate by check mark whether the Registrant is an accelerated filer (as defined in Rule 12b-2 of the Act).    Yes  x    No  ¨

 

APPLICABLE ONLY TO CORPORATE ISSUERS: Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date.

 

Number of Shares of Common Stock

Outstanding on October 31, 2003

  9,576,713

 



Table of Contents

QUAKER CHEMICAL CORPORATION AND CONSOLIDATED SUBSIDIARIES

 

PART I.

  

FINANCIAL INFORMATION

    

Item 1.

  

Financial Statements (unaudited)

    
    

Condensed Consolidated Balance Sheet at September 30, 2003 and December 31, 2002

   3
     Condensed Consolidated Statement of Income for the Three Months and Nine Months ended September 30, 2003 and 2002    4
     Condensed Consolidated Statement of Cash Flows for the Nine Months Ended September 30, 2003 and 2002    5
    

Notes to Condensed Consolidated Financial Statements

   6

Item 2.

  

Management’s Discussion and Analysis of Financial Condition and Results of Operations

   13

Item 3.

  

Quantitative and Qualitative Disclosures About Market Risk

   16

Item 4.

  

Controls and Procedures

   17

PART II.

  

OTHER INFORMATION

    

Item 6.

  

Exhibits and Reports on Form 8-K

   18

Signature

   18

 

* * * * * * * * * *

 

2


Table of Contents

Item 1. Financial Statements

 

Quaker Chemical Corporation

 

Condensed Consolidated Balance Sheet

 

    

Unaudited

(dollars in thousands, except

par value)


 
     September 30,
2003


    December 31,
2002 *


 

ASSETS

                

Current assets

                

Cash and cash equivalents

   $ 17,981     $ 13,857  

Accounts receivable, net

     73,953       53,353  

Inventories

                

Raw materials and supplies

     14,619       11,342  

Work-in-process and finished goods

     15,742       12,294  

Prepaid expenses and other current assets

     12,214       12,827  
    


 


Total current assets

     134,509       103,673  
    


 


Property, plant and equipment, at cost

     129,739       113,207  

Less accumulated depreciation

     72,650       64,695  
    


 


Net property, plant and equipment

     57,089       48,512  

Goodwill

     28,890       21,927  

Other intangible assets

     6,290       5,852  

Investments in associated companies

     5,736       9,060  

Deferred income taxes

     10,571       10,609  

Other assets

     15,734       14,225  
    


 


Total Assets

   $ 258,819     $ 213,858  
    


 


LIABILITIES AND SHAREHOLDERS’ EQUITY

                

Current liabilities

                

Short-term borrowings and current portion of long-term debt

   $ 28,991     $ 12,205  

Accounts and other payables

     35,420       29,423  

Accrued compensation

     7,317       10,254  

Other current liabilities

     15,326       14,262  
    


 


Total current liabilities

     87,054       66,144  

Long-term debt

     18,222       16,590  

Deferred income taxes

     1,744       1,518  

Other noncurrent liabilities

     37,004       33,889  
    


 


Total liabilities

     144,024       118,141  
    


 


Minority interest in equity of subsidiaries

     10,054       7,662  
    


 


Shareholders’ Equity

                

Common stock $1 par value; authorized 30,000,000 shares; issued (including treasury shares) 9,664,009 shares

     9,664       9,664  

Capital in excess of par value

     1,404       626  

Retained earnings

     115,216       110,448  

Unearned compensation

     (776 )     (1,245 )

Accumulated other comprehensive (loss)

     (19,018 )     (27,078 )
    


 


       106,490       92,415  

Treasury stock, shares held at cost; 2003 – 122,369, 2002 - 324,109

     (1,749 )     (4,360 )
    


 


Total shareholders’ equity

     104,741       88,055  
    


 


     $ 258,819     $ 213,858  
    


 


 

The accompanying notes are an integral part of these condensed consolidated financial statements.


* Condensed from audited financial statements.

 

3


Table of Contents

Quaker Chemical Corporation

 

Condensed Consolidated Statement of Income

 

    

Unaudited

(dollars in thousands, except per share data)


 
     Three Months ended
September 30,


    Nine Months ended
September 30,


 
     2003

    2002

    2003

    2002

 

Net sales

   $ 89,713     $ 73,268     $ 246,503     $ 202,652  

Cost of goods sold

     58,928       43,869       158,405       119,934  
    


 


 


 


Gross margin

     30,785       29,399       88,098       82,718  

Selling, general and administrative expenses

     24,459       22,697       70,367       66,000  
    


 


 


 


Operating income

     6,326       6,702       17,731       16,718  

Other income (expense), net

     295       942       830       1,194  

Interest expense

     (407 )     (491 )     (1,145 )     (1,318 )

Interest income

     167       22       531       571  
    


 


 


 


Income before taxes

     6,381       7,175       17,947       17,165  

Taxes on income

     1,683       2,296       5,384       5,493  
    


 


 


 


       4,698       4,879       12,563       11,672  

Equity in net income of associated companies

     215       130       470       314  

Minority interest in net income of subsidiaries

     (777 )     (720 )     (2,315 )     (2,103 )
    


 


 


 


Net income

   $ 4,136     $ 4,289     $ 10,718     $ 9,883  
    


 


 


 


Per share data:

                                

Net income – basic

   $ 0.44     $ 0.47     $ 1.15     $ 1.08  

Net income – diluted

   $ 0.42     $ 0.45     $ 1.11     $ 1.05  

Dividends declared

   $ 0.21     $ 0.21     $ 0.63     $ 0.63  

Based on weighted average number of shares outstanding:

                                

Basic

     9,410,675       9,222,050       9,335,628       9,149,337  

Diluted

     9,856,783       9,453,208       9,687,346       9,433,279  

 

The accompanying notes are an integral part of these condensed consolidated financial statements.

 

4


Table of Contents

Quaker Chemical Corporation

 

Condensed Consolidated Statement of Cash Flows

 

    

Unaudited

(dollars in thousands)

For the Nine Months
Ended September 30,


 
     2003

    2002

 

Cash flows from operating activities

                

Net income

   $ 10,718     $ 9,883  

Adjustments to reconcile net income to net cash provided by operating activities:

                

Depreciation

     5,246       3,571  

Amortization

     620       576  

Equity in net income of associated companies

     (470 )     (314 )

Minority interest in earnings of subsidiaries

     2,315       2,103  

Deferred compensation and other postretirement benefits

     257       290  

Pension and other, net

     2,995       1,885  

Increase (decrease) in cash from changes in current assets and current liabilities:

                

Accounts receivable, net

     (14,460 )     (3,375 )

Inventories

     (4,362 )     (2,543 )

Prepaid expenses and other current assets

     1,587       (1,326 )

Accounts payable and accrued liabilities

     (2,235 )     4,288  

Change in restructuring liabilities

     (908 )     (1,763 )
    


 


Net cash provided by operating activities

     1,303       13,275  
    


 


Cash flows from investing activities

                

Investments in property, plant and equipment

     (7,820 )     (7,642 )

Dividends and distributions from associated companies

     3,890       307  

Payments related to acquisitions

     (6,737 )     (21,285 )

Other, net

     (117 )     (443 )
    


 


Net cash (used in) investing activities

     (10,784 )     (29,063 )
    


 


Cash flows from financing activities

                

Net increase in short-term borrowings

     16,686       23,121  

Dividends paid

     (5,909 )     (5,756 )

Treasury stock issued

     3,106       2,618  

Distributions to minority shareholders

     (1,018 )     (1,514 )
    


 


Net cash provided by financing activities

     12,865       18,469  
    


 


Effect of exchange rate changes on cash

     740       (186 )
    


 


Net increase in cash and cash equivalents

     4,124       2,495  

Cash and cash equivalents at beginning of period

     13,857       20,549  
    


 


Cash and cash equivalents at end of period

   $ 17,981     $ 23,044  
    


 


 

The accompanying notes are an integral part of these condensed consolidated financial statements.

 

5


Table of Contents

Quaker Chemical Corporation

Notes to Condensed Consolidated Financial Statements

(Dollars in Thousands, except per share data)

(Unaudited)

 

Note 1 – Condensed Financial Information

 

The condensed consolidated financial statements included herein are unaudited and have been prepared in accordance with generally accepted accounting principles for interim financial reporting and Securities and Exchange Commission regulations. Certain information and footnote disclosures normally included in financial statements prepared in accordance with generally accepted accounting principles have been condensed or omitted pursuant to such rules and regulations. Certain prior year amounts have been reclassified to conform to the 2003 presentation. In the opinion of management, the financial statements reflect all adjustments (consisting only of normal recurring adjustments) which are necessary for a fair statement of the financial position, results of operations and cash flows for the interim periods. The results for the three and nine months ended September 30, 2003 are not necessarily indicative of the results to be expected for the full year. These financial statements should be read in conjunction with the Annual Report filed on Form 10-K for the year ended December 31, 2002.

 

As part of the Company’s chemical management services, certain third party products are transferred to customers. Where the Company acts as a principal, revenues are recognized on a gross reporting basis at the selling price negotiated with customers. Where the Company acts as an agent, such revenue is recorded using net reporting as service revenues, at the amount of the administrative fee earned by the Company for ordering the goods. Revenue for third party products transferred where the company acts as an agent and revenue is recorded on a net basis totaled $19,834 and $20,363 for the nine months ended September 30, 2003 and 2002, respectively.

 

Note 2 – Recently Issued Accounting Standards

 

In January 2003, the Financial Accounting Standards Board (“FASB”), issued FASB Interpretation No. 46 (“FIN 46”), “Consolidation of Certain Variable Interest Entities, (“VIEs”), which is an interpretation of Accounting Research Bulletin (“ARB”) No. 51, “Consolidated Financial Statements.” FIN 46 addresses the application of ARB No. 51 to VIEs, and generally would require that assets, liabilities and results of the activities of a VIE be consolidated into the financial statements of the enterprise that is considered the primary beneficiary. FIN 46, as amended by FASB staff position (“FSP”) No. FIN 46-6, is effective for interim or annual periods ending after December 15, 2003 to VIEs in which an enterprise holds a variable interest that it acquired before February 1, 2003. The Company has determined that its real estate joint venture is a VIE and that the Company is not the primary beneficiary.

 

In January 2001, the Company contributed its Conshohocken, Pennsylvania property and buildings (the “Site”) to this real estate joint venture (the “Venture”) in exchange for a 50% interest in the Venture. The Venture did not assume any debt or other obligations of the Company. The Venture renovated certain of the existing buildings at the Site, as well as built new office space (the “Project”). In December 2000, the Company entered into an agreement with the Venture to lease approximately 38% of the Site’s available office space for a 15-year period commencing February 2002, with multiple renewal options. As of September 30, 2003, approximately 93% of the Site’s office space was under lease and the Site (including improvements thereon) was subject to encumbrances securing indebtedness of the Venture in the amount of $26,976. The Company has not guaranteed nor is it obligated to pay any principal, interest or penalties on the indebtedness of the Venture, even in the event of default by the Venture. At September 30, 2003, the Venture had property with a net book value of $26,510, total assets of $29,121, and total liabilities of $27,293.

 

In April 2003, the FASB issued Statement of Financial Accounting Standards (“SFAS”) No. 149 “Amendment of Statement 133 on Derivative Instruments and Hedging Activities.” This standard amends and clarifies financial accounting and reporting for derivative instruments and hedging activities, primarily as a result of decisions made by the FASB Derivatives Implementation Group subsequent to the original issuance of SFAS No. 133 and in connection with other FASB projects. This standard is generally effective prospectively for contracts and hedging relationships entered into or modified after June 30, 2003. Management has assessed the impact of the new standard and determined there to be no material impact to the financial statements.

 

In May 2003, the FASB issued SFAS No. 150 “Accounting for Certain Financial Instruments with Characteristics of both Liabilities and Equity.” SFAS No. 150 changes the accounting for certain financial instruments that, under previous guidance, could be classified as equity or mezzanine equity, by now requiring those same instruments to be classified as liabilities (or assets in some circumstances) in the statement of financial position. Further, SFAS No. 150 requires disclosure regarding the terms of those instruments and settlement alternatives. The guidance in SFAS No. 150 is generally effective for all financial instruments

 

6


Table of Contents

entered into or modified after May 31, 2003, and is otherwise effective at the beginning of the first interim period beginning after June 15, 2003. On November 7, 2003, the FASB issued FSP FAS 150-3, which delayed the effective date for certain provisions of SFAS 150 indefinitely. For the effective provisions of the standard, management has assessed the impact and determined there to be no material impact to the financial statements. For the deferred provisions, the Company does not expect the pending adoption to have a material impact on the financial statements.

 

Note 3 – Stock-Based Compensation

 

In December 2002, the FASB issued Statement of Financial Accounting Standards (“SFAS”) No. 148, “Accounting for Stock-Based Compensation – Transition and Disclosure.” This standard amends the transition and disclosure requirements of SFAS No. 123, “Accounting for Stock-Based Compensation.” As permitted by SFAS No. 148, the Company continues to account for stock option grants in accordance with Accounting Principles Board Opinion No. 25, “Accounting for Stock Issued to Employees.” Accordingly, no compensation expense has been recognized for stock options since all options granted had an exercise price equal to the market value of the underlying stock on the grant date. The following tables illustrate the effect on net earnings and earnings per share if the Company had applied the fair value recognition provisions of SFAS No. 123.

 

    

Three Months

ended

September 30,


   

Nine Months

ended

September 30,


 
     2003

    2002

    2003

    2002

 

Net Income – as reported

   $ 4,136     $ 4,289     $ 10,718     $ 9,883  

Add: Stock-based employee compensation expense included in net income, net of related tax effects

     194       100       347       375  

Deduct: Total stock-based employee compensation expense determined under the fair value based method for all awards, net of tax

     (368 )     (228 )     (703 )     (733 )
    


 


 


 


Pro forma net income

   $ 3,962     $ 4,161     $ 10,362     $ 9,525  
    


 


 


 


Earnings per share:

                                

Basic – as reported

   $ 0.44     $ 0.47     $ 1.15     $ 1.08  

Basic – pro forma

   $ 0.42     $ 0.45     $ 1.11     $ 1.04  

Diluted – as reported

   $ 0.42     $ 0.45     $ 1.11     $ 1.05  

Diluted – pro forma

   $ 0.40     $ 0.44     $ 1.07     $ 1.01  

 

7


Table of Contents

Note 4 – Earnings Per Share

 

The following table summarizes earnings per share (EPS) calculations:

 

    

Three Months

Ended
September 30,


  

Nine Months

Ended
September 30,


     2003

   2002

   2003

   2002

Numerator for basic EPS and diluted EPS– net income

   $ 4,136    $ 4,289    $ 10,718    $ 9,883
    

  

  

  

Denominator for basic EPS–weighted average shares

     9,411      9,222      9,336      9,149

Effect of dilutive securities, primarily employee stock options

     446      231      351      284
    

  

  

  

Denominator for diluted EPS–weighted average shares and assumed conversions

     9,857      9,453      9,687      9,433
    

  

  

  

Basic EPS

   $ .44    $ .47    $ 1.15    $ 1.08

Diluted EPS

   $ .42    $ .45    $ 1.11    $ 1.05

 

8


Table of Contents

Note 5 – Business Segments

 

The Company’s reportable segments are as follows:

 

(1) Metalworking process chemicals – products used as lubricants for various heavy industrial and manufacturing applications.

 

(2) Coatings – temporary and permanent coatings for metal and concrete products and chemical milling maskants.

 

(3) Other chemical products – other various chemical products.

 

Segment data includes direct segment costs as well as general operating costs.

 

The table below presents information about the reported segments:

 

    

Three Months Ended

September 30,


   

Nine Months Ended

September 30,


 
     2003

    2002

    2003

    2002

 

Metalworking Process Chemicals

                                

Net Sales

   $ 82,490     $ 65,809     $ 225,464     $ 183,711  

Operating Income

     13,444       13,800       39,195       38,994  

Coatings

                                

Net Sales

     6,222       6,210       17,787       15,593  

Operating Income

     1,694       1,661       4,710       4,058  

Other Chemical Products

                                

Net Sales

     1,001       1,249       3,252       3,348  

Operating Income

     94       302       532       884  
    


 


 


 


Total

                                

Net Sales

     89,713       73,268       246,503       202,652  

Operating Income

     15,232       15,763       44,437       43,936  

Non-operating expenses

     (8,724 )     (8,810 )     (26,086 )     (26,642 )

Amortization

     (182 )     (251 )     (620 )     (576 )

Interest expense

     (407 )     (491 )     (1,145 )     (1,318 )

Interest income

     167       22       531       571  

Other income, net

     295       942       830       1,194  
    


 


 


 


Consolidated income before taxes

   $ 6,381     $ 7,175     $ 17,947     $ 17,165  
    


 


 


 


 

Operating income comprises revenue less related costs and expenses. Non-operating items primarily consist of general corporate expenses identified as not being a cost of operation, interest expense, interest income, and license fees from non-consolidated associates.

 

9


Table of Contents

Note 6 – Comprehensive Income

 

The following table summarizes comprehensive income:

 

    

Three Months Ended

September 30,


    Nine Months Ended
September 30,


 
     2003

   2002

    2003

   2002

 

Net income

   $ 4,136    $ 4,289     $ 10,718    $ 9,883  

Unrealized gain on available-for-sale securities

     197      —         197      —    

Foreign currency translation adjustments

     1,195      (2,865 )     7,863      (2,422 )
    

  


 

  


Comprehensive income

   $ 5,528    $ 1,424     $ 18,778    $ 7,461  
    

  


 

  


 

Note 7 – Restructuring and Related Activities

 

In 2001, Quaker’s management approved restructuring plans to realign its organization and reduce operating costs. Quaker’s restructuring plans included the closure and sale of its manufacturing facilities in the U.K. and France. In addition, Quaker consolidated certain functions within its global business units and reduced administrative functions, as well as expensed costs related to abandoned acquisitions. Included in the restructuring charges are provisions for the severance of 53 employees.

 

Restructuring and related charges of $5,854 were recognized in 2001. The charge comprised $2,644 related to employee separations, $2,613 related to facility rationalization charges and $597 related to abandoned acquisitions. Employee separation benefits under each plan varied depending on local regulations within certain foreign countries and included severance and other benefits. As of September 30, 2003, Quaker had completed 50 of the planned 53 employee separations under the 2001 plans. During the fourth quarter of 2002, the Company completed the sale of its U.K. manufacturing facility. Quaker closed this facility at the end of 2001. Quaker currently expects to substantially complete the initiatives contemplated under the restructuring plans, including the sale of its manufacturing facility in France, by early 2004.

 

Accrued restructuring balances, included in other current liabilities, are as follows:

 

   

Balance

December 31,

2002


   Payments

    

Currency

translation

and other


 

Balance

September 30,

2003


Employee separations

  $ 1,274    $ (758 )    $ 12   $ 528

Facility rationalization

    869      (150 )      8     727
   

  


  

 

Total

  $ 2,143    $ (908 )    $ 20   $ 1,255
   

  


  

 

 

Note 8 – Business Acquisition

 

In May 2003, the Company acquired a range of cleaners, wet temper fluids and other products from KS Chemie, located in Dusseldorf, Germany for approximately $1,100. This acquisition strategically strengthens the Company’s global leadership position as a process fluids supplier to the steel industry. The Company recorded $400 of intangible assets comprised of product line technology to be amortized over a range of five to ten years. The Company also recorded $600 of goodwill, which was assigned to the Metalworking process chemicals segment. The pro forma results of operations have not been provided because the effects were not material.

 

In July 2003, the Company acquired all of the outstanding stock of Eural S.r.l., a privately held company located in Tradate, Italy for $5,700. Eural manufactures a variety of specialty metalworking fluids primarily for the Italian market. The Company has preliminarily allocated approximately $3,050 to current assets; $3,150 to property, plant and equipment; $675 to intangible assets; $4,075 to current liabilities; $1,750 to non-current liabilities; and $4,650 to goodwill. Pro-forma results of operations have not been presented because the effects were not material.

 

10


Table of Contents

Note 9 – Goodwill and Other Intangible Assets

 

The Company completed its annual impairment assessment as of the end of the third quarter 2003 and no impairment charge was warranted. The changes in carrying amount of goodwill for the nine months ended September 30, 2003 are as follows:

 

    

Metalworking

process chemicals


   Coatings

   Total

Balance as of January 1, 2003

   $ 14,658    $ 7,269    $ 21,927

Goodwill additions

     5,310      —        5,310

Currency translation adjustments

     1,653      —        1,653
    

  

  

Balance as of September 30, 2003

   $ 21,621    $ 7,269    $ 28,890
    

  

  

 

Gross carrying amounts and accumulated amortization for intangible assets as of September 30, 2003, are as follows:

 

    

Gross carrying

Amount


  

Accumulated

Amortization


 

Amortized intangible assets

               

Customer lists and rights to sell

   $ 3,850    $ (665 )

Trademarks and patents

     2,379      (1,563 )

Formulations and product technology

     2,215      (341 )

Other

     1,694      (1,279 )
    

  


Total

   $ 10,138    $ (3,848 )
    

  


 

Estimated annual aggregate amortization expense for the current year and subsequent five years is as follows:

 

For the year ended December 31, 2003

   $ 904

For the year ended December 31, 2004

   $ 873

For the year ended December 31, 2005

   $ 840

For the year ended December 31, 2006

   $ 823

For the year ended December 31, 2007

   $ 411

For the year ended December 31, 2008

   $ 324

 

Note 10 – Debt

 

In June 2003, the Company entered into a $10,000 committed credit facility with a bank, which expires in June 2004. At the Company’s option, the interest rate for borrowings under the agreement may be based on the eurodollar rate plus a margin or the

 

11


Table of Contents

prime rate plus a margin. In July 2003, an amendment increased this committed credit facility to $15,000. The provisions of the agreement require that the Company maintain certain financial ratios and covenants, all of which the Company was in compliance with as of September 30, 2003.

 

In June 2003, the Company entered into a $10,000 uncommitted demand credit facility, with a different bank. At the Company’s option, the interest rate for borrowings under this agreement may be based on the prime rate or the LIBOR rate plus a margin.

 

As a result of these agreements, the Company increased its credit facilities from $15,000 committed and $10,000 uncommitted at the end of March 2003 to its current position of $30,000 committed and $20,000 uncommitted. The Company had approximately $26,134 and $23,260 outstanding on its credit facilities as of September 30, 2003 and 2002, respectively.

 

Note 11 – Commitments and Contingencies

 

The Company is involved in environmental clean-up activities and litigation in connection with an existing plant location and former waste disposal sites. The Company identified certain soil and groundwater contamination at AC Products, Inc. (“ACP”), a wholly owned subsidiary. In coordination with the Santa Ana California Regional Water Quality Board, ACP is remediating the contamination. The Company believes that the remaining potential-known liabilities associated with these matters ranges from approximately $900 to $1,400, for which the Company has sufficient reserves. Notwithstanding the foregoing, the Company cannot be certain that liabilities in the form of remediation expenses, fines, penalties, and damages will not be incurred in excess of the amount reserved.

 

An inactive subsidiary of the Company that was acquired in 1978 sold certain products containing asbestos, primarily on an installed basis, and is among the defendants in numerous lawsuits alleging injury due to exposure to asbestos. The subsidiary discontinued operations in 1991 and has no remaining assets other than its existing insurance policies. To date, the overwhelming majority of these claims have been disposed of without payment and there have been no adverse judgments against the subsidiary. Based on an initial analysis of the existing and anticipated future claims against this subsidiary, it is currently projected that the subsidiary’s total liability over the next 50 years for these claims is approximately $15,000 (excluding the costs of defense). Although the Company has also been named as a defendant in certain of these cases, no claims have been actively pursued against the Company and the Company has not contributed to the defense or settlement of any of these cases pursued against the subsidiary. These cases have been handled to date by the subsidiary’s primary and excess insurers who agreed to pay all defense costs and be responsible for all damages assessed against the subsidiary arising out of existing and future asbestos claims up to the aggregate limits of the policies. A significant portion of the primary insurance coverage was provided by an insurer that is now insolvent, and the other primary insurers have recently asserted that the aggregate limits of their policies have been exhausted. The subsidiary is challenging the applicability of these limits to the claims being brought against the subsidiary. The subsidiary has additional coverage under its excess policies. The Company believes, however, that if the coverage issues under the primary policies are resolved adversely to the subsidiary, the subsidiary’s insurance coverage will likely be exhausted within the next three to four years. As a result, liabilities in respect of claims not yet asserted may exceed coverage available to the subsidiary.

 

If the subsidiary’s insurance coverage were to be exhausted, claimants of the subsidiary may actively pursue claims against the Company because of the parent-subsidiary relationship. Although asbestos litigation is particularly difficult to predict, especially with respect to claims that are currently not being actively pursued against the Company, the Company does not believe that such claims would have merit or that the Company would be held to have liability for any unsatisfied obligations of the subsidiary as a result of such claims. After evaluating the nature of the claims filed against the subsidiary and the small number of such claims that have resulted in any payment, the potential availability of additional insurance coverage at the subsidiary level, the additional availability of the Company’s own insurance coverage and the Company’s strong defenses to claims that it should be held responsible for the subsidiary’s obligations because of the parent-subsidiary relationship, the Company believes that the inactive subsidiary’s liabilities will not have a material impact on the Company’s financial condition, cash flows or results of operations.

 

The Company is party to other litigation which management currently believes will not have a material adverse effect on the Company’s results of operations, cash flows or financial condition.

 

Note 12 – Subsequent Events

 

In October 2003, the Company acquired the assets of the steel and food-grade lubricants business from the Cincinnati-Vulcan Company for approximately $8,800. This acquisition further strengthens Quaker’s global leadership supply position to the steel industry.

 

12


Table of Contents

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

 

Liquidity and Capital Resources

 

Quaker’s cash and cash equivalents increased to $18.0 million at September 30, 2003 from $13.9 million at December 31, 2002. The increase resulted primarily from $1.3 million cash and $12.9 million cash provided by operating activities and financing activities, respectively, offset by, $10.8 million cash used in investing activities.

 

Net cash flows provided by operating activities were $1.3 million in the first nine months of 2003 compared to cash flows provided by operating activities of $13.3 million in the same period of 2002. The decrease was primarily due to increased cash out flows from working capital accounts offset by higher net income, depreciation and amortization expense. The change in cash flows from accounts receivable was primarily due to increased business activity and $17.1 million of sales attributable to the Company’s recently awarded chemical management services (CMS) contracts, which were effective May 1, 2003. Increased business activity, including the Company’s new CMS contracts, as well as higher raw material costs accounted for the change in cash flows related to inventories. Increased cash flows from prepaid expenses and other current assets versus the prior year is primarily due to a $2.6 million refund related to a settlement from a tax audit at one of our foreign entities. The change in cash flows from accounts payable and accrued liabilities is due to higher annual incentive compensation payments as well as timing related to high levels of accounts payable at December 31, 2002.

 

Net cash flows used in investing activities were $10.8 million in the first nine months of 2003 compared to $29.1 million in the same period of 2002. The decrease was primarily related to $21.3 million cash used in the first nine months of 2002 for the acquisitions of United Lubricants Corporation (“ULC”) and Epmar Corporation (“Epmar”) versus the $6.8 million used in 2003 for the acquisition of certain product lines from KS Chemie and the acquisition of Eural, S.r.l. Reference is made to Note 8 of the notes to condensed consolidated financial statements which appears in Item 1 of this Quarterly Report on Form 10-Q. In addition, the Company also received $4.2 million of priority cash distributions from its real estate joint venture in the first nine months of 2003.

 

Net cash flows provided by financing activities were $12.9 million for the first nine months of 2003 compared to $18.5 million for the same period of the prior year. The net change was primarily due to changes in short-term borrowings. $23.1 million of short term borrowings were incurred in the first nine months of 2002 used to finance the Company’s acquisitions of ULC and Epmar versus $16.7 million in 2003 used to finance the KS Chemie and Eural acquisitions as well as to fund working capital needs.

 

In June 2003, the Company entered into a $10.0 million committed credit facility with a bank, which expires in June 2004. At the Company’s option, the interest rate for borrowings under the agreement may be based on the eurodollar rate plus a margin or the prime rate plus a margin. In July 2003, an amendment increased this committed credit facility to $15.0 million. The provisions of the agreement require that the Company maintain certain financial ratios and covenants, all of which the Company was in compliance with as of September 30, 2003.

 

In June 2003, the Company entered into a $10.0 million uncommitted demand credit facility, with a different bank. At the Company’s option, the interest rate for borrowings under this agreement may be based on the prime rate or the LIBOR rate plus a margin.

 

As a result of these agreements, the Company has increased its credit facilities from $15.0 million committed and $10.0 million uncommitted at the end of March 2003 to its current position of $30.0 million committed and $20.0 million uncommitted. The Company had approximately $26.1 and $23.3 million outstanding on its credit facilities as of September 30, 2003 and 2002, respectively.

 

The Company believes that its balance sheet remains strong with a debt to total capital ratio of 31% at September 30, 2003 compared to 25% at the end of 2002 and 35% at September 30, 2002. The Company further believes it is capable of supporting its operating requirements including pension plan contributions, payment of dividends to shareholders, possible acquisition and business opportunities, capital expenditures and possible resolution of contingencies through internally generated funds supplemented with debt as needed.

 

13


Table of Contents

Operations

 

Comparison of First Nine Months 2003 with First Nine Months 2002

 

Consolidated net sales for the first nine months of the year increased to a record $246.5 million, up 22% from $202.7 million for the first nine months of 2002. Foreign exchange rate translation and the timing of the Company’s 2002 and 2003 acquisitions favorably impacted net sales by $11.1 million and $9.5 million, respectively. Year-to-date 2003 consolidated net sales also include $17.1 million from the Company’s recently awarded Chemical Management Services (CMS) contracts, which were effective May 1, 2003. The remaining increase in net sales is primarily due to double digit growth in the Asia Pacific and South American regions offset by a decline in business in the U.S.

 

Gross margin as a percentage of sales declined from 40.8% for the first nine months of 2002 to 35.7% for the first nine months of 2003. As previously disclosed, the Company’s new CMS contracts have caused different relationships between margins and revenue than in the past. At the majority of current CMS sites, the Company effectively acts as an agent and records revenue and costs from these sales on a net sales or “pass-through” basis. The new CMS contracts have a different structure, which results in the Company recognizing in reported revenue the gross revenue received from the CMS site customer and in cost of goods sold the third party product purchases, which substantially offset each other. The negative impact to gross margin for the first nine months of 2003 is approximately 3 percentage points. The Company expects the negative impact to gross margin for the full year 2003, related to the new CMS contracts, to be approximately 4 to 5 percentage points. The remaining decline in gross margin as a percentage of sales was due to increased raw material costs, as well as product and regional sales mix. The Company had expected raw material costs to decline in the second half of 2003 due to the projected decline in world crude oil prices. However, the Company now expects raw material prices to remain at current levels in the near term.

 

Selling, general and administrative (SG&A) expenses for the first nine months of 2003 increased $4.4 million from the first nine months of 2002. Approximately $4.3 million of the increase is due to changes in foreign exchange rates and the Company’s acquisitions. The remainder of the increase is primarily due to higher pension costs and the Company’s continued implementation of its global ERP system partially offset by reduced incentive compensation expense.

 

The year-to-date decline in other income of approximately $0.4 million as compared to the first nine months of 2002 was primarily due to foreign exchange gains of approximately $0.6 million realized in 2002 as a result of the weakening of the Brazilian Real and its impact on the U.S. dollar denominated cash balances in Brazil. This decline was partially offset by a $0.3 million favorable impact related to the $4.2 million of priority cash distributions received from the Company’s real estate joint venture during the first half of 2003. Interest expense is below the prior year primarily due to decreased average debt levels and slightly lower borrowing rates.

 

The year-to-date 2003 effective tax rate is 30% compared to 32% in the prior year and in the first six months of 2003. The decrease in the effective tax rate is primarily due to the Company’s favorable settlement of outstanding tax audits and appeal issues related to several foreign subsidiaries. The Company currently anticipates that its effective tax rate will remain at 30% for the full 2003 year, and it is likely that the effective rate will return to more historic levels in future years.

 

The increase in equity income for the first nine months of 2003 is due to improved results from the Company’s real estate joint venture offset in part by the consolidation of the Company’s South African joint venture effective July 1, 2002. The increase in minority interest was primarily due to the consolidation of the Company’s South African joint venture.

 

Comparison of Third Quarter 2003 with Third Quarter 2002

 

Consolidated net sales for the third quarter of 2003 were a record $89.7, a 22% increase compared to the third quarter of 2002. Foreign exchange rate translation and the Company’s 2003 acquisitions favorably impacted third quarter 2003 net sales by $4.8 million and $1.3 million, respectively. Third quarter 2003 sales also include $9.7 million from the Company’s recently awarded CMS contracts. The remaining increase in net sales is primarily due to double-digit growth in the Asia Pacific and South American regions offset by a decline in business in the U.S.

 

Gross margin as a percentage of sales declined from 40.1% for the third quarter of 2002 to 34.3% for the third quarter of 2003. The Company’s new CMS contracts negatively impacted gross margin for the third quarter 2003 by approximately 4 percentage points. The remaining decline in gross margin as a percentage of sales was due to increased raw material costs, as well as product and regional sales mix.

 

Selling, general and administrative (SG&A) expenses for the quarter increased $1.8 million as compared to the third quarter of 2002. Approximately $1.4 million of the increase is due to foreign exchange rates and the Company’s 2003 acquisitions. Increases in other expenses, including pension and the Company’s continued rollout of its global ERP system, were largely offset by reduced incentive compensation expense.

 

The decrease in other income is primarily due to foreign exchange gains realized in 2002 as a result of the weakening of the Brazilian Real and its impact on the U.S. dollar denominated cash balances in Brazil. Interest expense is below the prior year due to decreased average debt levels and slightly lower borrowing rates. The increase in interest income is primarily due to higher interest income from the Company’s international affiliates such as Brazil.

 

14


Table of Contents

The effective tax rate for the third quarter 2003 is 26% down from 32% in the third quarter of 2002. The decrease in the effective tax rate is primarily due to the Company’s favorable settlement of outstanding tax audits and appeal issues related to several foreign subsidiaries.

 

The increase in equity income for the third quarter of 2003 is primarily due to improved results from the Company’s real estate joint venture. Minority interest was essentially flat compared to the same period in the prior year.

 

Other Significant Items

 

In May 2003, the Company acquired a range of cleaners, wet temper fluids and other products from KS Chemie, located in Dusseldorf, Germany for approximately $1.1 million. This acquisition strategically strengthens the Company’s global leadership position as a process fluids supplier to the steel industry.

 

In July 2003, the Company acquired all of the outstanding stock of Eural S.r.l., a privately held company located in Tradate, Italy for $5.7 million. Eural manufactures a variety of specialty metalworking fluids primarily for the Italian market.

 

In October 2003, the Company acquired the assets of the steel and food-grade lubricants business from the Cincinnati-Vulcan company for approximately $8.8 million. This acquisition further strengthens the Company’s global leadership supply position to the steel industry.

 

Factors that May Affect our Future Results

 

(Cautionary Statements Under the Private Securities Litigation Reform Act of 1995)

 

Certain information included in this Report and other materials filed or to be filed by Quaker with the Securities and Exchange Commission (as well as information included in oral statements or other written statements made or to be made by us) contains or may contain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These Statements can be identified by the fact that they do not relate strictly to historical or current facts. We have based these forward-looking statements on our current expectations about future events. These forward-looking statements include statements with respect to our beliefs, plans, objectives, goals, expectations, anticipations, intentions, financial condition, results of operations, future performance and business, including:

 

  Statements relating to our business strategy;

 

  Our current and future results and plans; and

 

  Statements that include the words “may,” “could,” “should,” “would,” “believe,” “expect,” “anticipate,” “estimate,” “intend,” “plan” or similar expressions.

 

These forward looking statements are subject to risks, uncertainties and assumptions about us and our operations that are subject to change based on various important factors, some of which are beyond our control.

 

A major risk is that the Company’s demand is largely derived from the demand for its customers’ products, which subjects the Company to uncertainties related to downturns in a customer’s business and unanticipated customer production planning curtailments. Other major risks and uncertainties include, but are not limited to, significant increases in raw material costs, worldwide economic and political conditions, foreign currency fluctuations, and terrorist attacks such as those that occurred on September 11, 2001. Furthermore, the Company is subject to the same business cycles as those experienced by steel, automobile, aircraft, appliance, and durable goods manufacturers. These risks, uncertainties, and possible inaccurate assumptions relevant to our business could cause our actual results to differ materially from expected and historical results. Other factors beyond those discussed could also adversely affect us. Therefore, we caution you not to place undue reliance on our forward looking statements. This discussion is provided as permitted by the Private Securities Litigation Reform Act of 1995.

 

15


Table of Contents

Item 3. Quantitative and Qualitative Disclosures About Market Risk.

 

Quaker is exposed to the impact of interest rates, foreign currency fluctuations, changes in commodity prices, and credit risk.

 

Interest Rate Risk. Quaker’s exposure to market rate risk for changes in interest rates relates primarily to its short and long-term debt. Most of Quaker’s long-term debt has a fixed interest rate, while its short-term debt is negotiated at market rates which can be either fixed or variable. Incorporated by reference is the information under the caption “Liquidity and Capital Resources” in Management’s Discussion and Analysis of Financial Condition and Results of Operations and Note 8 of the Notes to Consolidated Financial Statements beginning on pages 11 and 33, respectively, of the Registrant’s Annual Report on Form 10-K for the year ended December 31, 2002 (the “2002 Form 10-K”). If interest rates rise significantly, the cost of short-term debt to Quaker will increase. This can have a material adverse effect on Quaker depending on the extent of Quaker’s short-term borrowings. As of September 30, 2003, Quaker had $26.1 million of short-term borrowings compared to $9.3 million as of December 31, 2002.

 

Foreign Exchange Risk. A significant portion of Quaker’s revenues and earnings is generated by its foreign operations. Incorporated by reference is the information concerning Quaker’s non-U.S. activities appearing in Note 11 of the Notes to Consolidated Financial Statements beginning on page 38 of the 2002 Form 10-K. All such subsidiaries use the local currency as their functional currency. Accordingly, Quaker’s financial results are affected by risks typical of global business such as currency fluctuations, particularly between the U.S. dollar, the Brazilian real and the E.U. euro. As exchange rates vary, Quaker’s results can be materially affected.

 

In the past, Quaker has used, on a limited basis, forward exchange contracts to hedge foreign currency transactions and foreign exchange options to reduce exposure to changes in foreign exchange rates. The amount of any gain or loss on these derivative financial instruments was immaterial.

 

Commodity Price Risk. Many of the raw materials used by Quaker are commodity chemicals, and, therefore, Quaker’s earnings can be materially adversely affected by market changes in raw material prices. In certain cases, Quaker has entered into fixed-price purchase contracts having a term of up to one year. These contracts provide for protection to Quaker if the price for the contracted raw materials rises, however, in certain limited circumstances, Quaker will not realize the benefit if such prices decline.

 

Credit Risk. Quaker establishes allowances for doubtful accounts for estimated losses resulting from the inability of its customers to make required payments. If the financial condition of Quaker’s customers were to deteriorate, resulting in an impairment of their ability to make payments, additional allowances may be required. Downturns in the overall economic climate may also tend to exacerbate specific customer financial issues. A significant portion of Quaker’s revenues is derived from sales to customers in the U.S. steel industry where a number of bankruptcies occurred during recent years. In 2000, 2001, and early 2002, Quaker recorded additional provisions for doubtful accounts primarily related to bankruptcies in the U.S. steel industry. When a bankruptcy occurs, Quaker must judge the amount of proceeds, if any, that may ultimately be received through the bankruptcy or liquidation process. As part of its terms of trade, Quaker may custom manufacture products for certain large customers and/or may ship product on a consignment basis. These practices may increase the Company’s exposure should a bankruptcy occur, and may require writedown or disposal of certain inventory due to its estimated obsolescence or limited marketability. Customer returns of products or disputes may also result in similar issues related to the realizability of recorded accounts receivable or returned inventory. Incorporated by reference is the information under the captions “Critical Accounting Policies and Estimates” and “Liquidity and Capital Resources” in Management’s Discussion and Analysis of Financial Condition and Results of Operations beginning on pages 8 and 11 respectively, of the 2002 Form 10-K.

 

16


Table of Contents

Item 4. Controls and Procedures

 

Evaluation of disclosure controls and procedures. The Company’s principal executive officer and principal financial officer have concluded that the Company’s disclosure controls and procedures (as defined in Exchange Act Rule 13a-15(e)), based on their evaluation of such controls and procedures as of the end of the period covered by this Quarterly Report on Form 10-Q, are effective to reasonably assure that information required to be disclosed by the Company in the reports it files under the Securities Exchange Act of 1934, as amended, is recorded, processed, summarized and reported within the time periods specified in the rules and forms of the Securities and Exchange Commission.

 

Changes in internal controls. As previously disclosed, the Company is in the process of implementing a global ERP system. The Company completed its initial implementation of this system in The Netherlands during the fourth quarter of 2002. In the second quarter of 2003, the Company implemented the ERP system in its Spanish subsidiary. During the fourth quarter of 2003, the Company plans to implement the system in its US Operations. By the end of 2003, subsidiaries representing more than 50% of consolidated revenue are expected to be operational on the global ERP system. Additional subsidiaries are planned to be implemented during 2004 and 2005. The Company is taking the necessary steps to monitor and maintain the appropriate internal controls during this period of change.

 

17


Table of Contents

PART II. OTHER INFORMATION

 

Items 1,2,3,4 and 5 of Part II are inapplicable and have been omitted.

 

Item 6: Exhibits and Reports on Form 8-K

 

(a) Exhibits.

 

31.1 –

  Certification of Chief Executive Officer of the Company pursuant to Rule 13a-14(a) of the Securities Exchange Act of 1934

31.2 –

  Certification of Chief Financial Officer of the Company pursuant to Rule 13a-14(a) of the Securities Exchange Act of 1934

32.1 –

  Certification of Ronald J. Naples Pursuant to 18 U.S. C. Section 1350

32.2 –

  Certification of Michael F. Barry Pursuant to 18 U.S. C. Section 1350

 

(b) Reports on Form 8-K.

 

1. On August 1, 2003 the Company furnished on Form 8-K its Second Quarter 2003 Press Release.

 

* * * * * * * * *

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

QUAKER CHEMICAL CORPORATION


(Registrant)

/s/ MICHAEL F. BARRY


Michael F. Barry, officer duly

authorized to sign this report,

Vice President and Chief Financial Officer

 

Date: November 14, 2003

 

18

SECTION 302 CEO CERTIFICATION

EXHIBIT 31.1

 

CERTIFICATION OF CHIEF EXECUTIVE OFFICER OF THE COMPANY PURSUANT TO RULE

13A-14(A) OF THE SECURITIES EXCHANGE ACT OF 1934

 

I, Ronald J. Naples, certify that:

 

1. I have reviewed this quarterly report on Form 10-Q of Quaker Chemical Corporation;

 

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by the report;

 

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations, and cash flows of the registrant as of, and for, the periods presented in this report;

 

4. The registrant’s other certifying officers and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and have:

 

  (a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

  (b) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

  (c) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5. The registrant’s other certifying officers and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of registrant’s board of directors (or persons performing the equivalent functions):

 

  (a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

  (b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Date: November 14, 2003

 

/s/ Ronald J. Naples


Ronald J. Naples

Chief Executive Officer

SECTION 302 CFO CERTIFICATION

EXHIBIT 31.2

 

CERTIFICATION OF CHIEF FINANCIAL OFFICER OF THE COMPANY PURSUANT TO RULE

13A-14(A) OF THE SECURITIES EXCHANGE ACT OF 1934

 

I, Michael F. Barry, certify that:

 

1. I have reviewed this quarterly report on Form 10-Q of Quaker Chemical Corporation;

 

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by the report;

 

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations, and cash flows of the registrant as of, and for, the periods presented in this report;

 

4. The registrant’s other certifying officers and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and have:

 

  (a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

  (b) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

  (c) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5. The registrant’s other certifying officers and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of registrant’s board of directors (or persons performing the equivalent functions):

 

  (a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

  (b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Date: November 14, 2003

 

/s/ Michael F. Barry


Michael F. Barry

Chief Financial Officer

SECTION 906 CEO CERTIFICATION

EXHIBIT 32.1

 

CERTIFICATION PURSUANT TO 18 U.S. C. SECTION 1350

 

The undersigned hereby certifies that the Form 10-Q Quarterly Report of Quaker Chemical Corporation (the “Company”) for the quarterly period ended September 30, 2003 filed with the Securities and Exchange Commission (the “Report”) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and that the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

Dated: November 14, 2003

 

/s/ Ronald J. Naples


   

Ronald J. Naples

   

Chief Executive Officer of Quaker

   

Chemical Corporation

SECTION 906 CFO CERTIFICATION

EXHIBIT 32.2

 

CERTIFICATION PURSUANT TO 18 U.S. C. SECTION 1350

 

The undersigned hereby certifies that the Form 10-Q Quarterly Report of Quaker Chemical Corporation (the “Company”) for the quarterly period ended September 30, 2003 filed with the Securities and Exchange Commission (the “Report”) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and that the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

Dated: November 14, 2003

 

/s/ Michael F. Barry


   

Michael F. Barry

   

Chief Financial Officer of Quaker

   

Chemical Corporation